252210-08-5

Upstream product

• 252210-04-1 (3-azidopropyl) 2,3,4,6-tetra-O-acetate-α-D-mannopyranoside 
• 252210-03-0 5-(azidomethyl)benzene-1,3-dicarbonyl dichloride 
• 252210-05-2 (2R,3R,4S,5S,6S)-2-(acetoxymethyl)-6-(3-aminopropoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 252210-02-9 5-azidomethylbenzene-1,3-dicarboxylic acid 
• 178056-30-9 dimethyl 5-azidomethylbenzene-1,3-dicarboxylate 
• 252210-01-8 dimethyl 5-chloromethyl-1,3-benzenedicarboxylate 
• 121238-27-5 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl trichloroimidate 
• 109862-53-5 dimethyl 5-hydroxymethylbenzene-1,3-dicarboxylate 
• 38588-64-6 3,5-bis(methoxycarbonyl)benzoic acid 
• 2672-58-4 1,3,5-tris-(methoxycarbonyl)benzene 
• 554-95-0 benzene-1,3,5-tricarboxylic acid 

Downstream Products

• 252210-12-1 Acetic acid (2R,3R,4S,5S,6S)-3,5-diacetoxy-2-acetoxymethyl-6-(3-{3-aminomethyl-5-[3-((2S,3S,4S,5R,6R)-3,4,5-triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yloxy)-propylcarbamoyl]-benzoylamino}-propoxy)-tetrahydro-pyran-4-yl ester 

Relevant academic research and scientific papers

On the meaning of affinity: Cluster glycoside effects and concanavalin a

The inhibition of protein - carbohydrate interaction provides a powerful therapeutic strategy for the treatment of myriad human diseases. To date, application of such approaches have been frustrated by the inherent low affinity of carbohydrate ligands for